Please use this identifier to cite or link to this item:
https://ninho.inca.gov.br/jspui/handle/123456789/5049Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | INCA | - |
| dc.contributor.author | Instituto Nacional de Câncer (Brasil) | - |
| dc.contributor.author | Instituto Nacional de Câncer José Alencar Gomes da Silva | - |
| dc.contributor.author | Sistema Único de Saúde (Brasil) | - |
| dc.contributor.author | Brasil. Ministério da Saúde | - |
| dc.date.accessioned | 2022-02-09T17:23:45Z | - |
| dc.date.available | 2022-02-09T17:23:45Z | - |
| dc.date.issued | 2021-12 | - |
| dc.identifier.uri | http://sr-vmlxaph03:8080/jspui/handle/123456789/5049 | - |
| dc.description | 2 p. | - |
| dc.language.iso | Port | pt_BR |
| dc.publisher | INCA | pt_BR |
| dc.relation.ispartofseries | Ano V, n. 55. | - |
| dc.subject | Trastuzumab | pt_BR |
| dc.subject | Trastuzumab | pt_BR |
| dc.subject | Neoplasias de la Mama/tratamiento farmacológico | pt_BR |
| dc.subject | Neoplasias da Mama/tratamento farmacológico | pt_BR |
| dc.subject | Breast Neoplasms/drug therapy | pt_BR |
| dc.title | Trastuzumabe e pertuzumabe versus acomentimento visceral | pt_BR |
| dc.Type | Revistas/Boletins | pt_BR |
| Appears in Collections: | Informe SUS - ONCO 2021 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Dezembro_2021 (3).pdf | 482.91 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.